ATE85707T1 - Entwicklungsverfahren fuer arzneimittel zur behandlung von stoerungen. - Google Patents

Entwicklungsverfahren fuer arzneimittel zur behandlung von stoerungen.

Info

Publication number
ATE85707T1
ATE85707T1 AT85906005T AT85906005T ATE85707T1 AT E85707 T1 ATE85707 T1 AT E85707T1 AT 85906005 T AT85906005 T AT 85906005T AT 85906005 T AT85906005 T AT 85906005T AT E85707 T1 ATE85707 T1 AT E85707T1
Authority
AT
Austria
Prior art keywords
abnormal
treatment
disorders
patterns
drug development
Prior art date
Application number
AT85906005T
Other languages
English (en)
Inventor
Wayne R Matson
Original Assignee
Esa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esa Inc filed Critical Esa Inc
Application granted granted Critical
Publication of ATE85707T1 publication Critical patent/ATE85707T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/64—Electrical detectors
    • G01N2030/645—Electrical detectors electrical conductivity detectors

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
AT85906005T 1984-11-13 1985-11-13 Entwicklungsverfahren fuer arzneimittel zur behandlung von stoerungen. ATE85707T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67048384A 1984-11-13 1984-11-13
EP85906005A EP0201591B1 (de) 1984-11-13 1985-11-13 Entwicklungsverfahren für arzneimittel zur behandlung von störungen
PCT/US1985/002256 WO1986003006A1 (en) 1984-11-13 1985-11-13 Method for biological testing and/or developing pharmaceuticals for treatment of disorders

Publications (1)

Publication Number Publication Date
ATE85707T1 true ATE85707T1 (de) 1993-02-15

Family

ID=24690574

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85906005T ATE85707T1 (de) 1984-11-13 1985-11-13 Entwicklungsverfahren fuer arzneimittel zur behandlung von stoerungen.

Country Status (6)

Country Link
EP (1) EP0201591B1 (de)
JP (1) JPS62500805A (de)
AT (1) ATE85707T1 (de)
AU (1) AU5202186A (de)
DE (1) DE3587091T2 (de)
WO (1) WO1986003006A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3643779A1 (de) * 1986-12-20 1988-07-07 Philips Patentverwaltung Geraet zum aufnehmen und/oder wiedergeben von signalen auf informationsplatten mit einem lichtoptischen einschreibe- und/oder ausleseaggregat (auto-cd-spieler)
DE69214628T2 (de) * 1991-01-18 1997-05-22 Esa Inc Verfahren zur Diagnose von Störungen der Körperfunktionen unter Verwendung von biochemischen Pryfilen
WO1998040748A1 (en) * 1997-03-14 1998-09-17 Neuromark Diagnosing neurologic disorders
DE19857349A1 (de) * 1998-12-11 2000-06-15 Wolfgang Schnizer Hautpflege-System
US20020009740A1 (en) * 2000-04-14 2002-01-24 Rima Kaddurah-Daouk Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
WO2008033575A2 (en) 2006-09-15 2008-03-20 Metabolon, Inc. Methods of identifying biochemical pathways
EP3017300A4 (de) * 2013-07-01 2017-03-08 Ixcela, Inc. Systembiologischer therapieansatz
ES2825105T3 (es) 2014-04-08 2021-05-14 Metabolon Inc Obtención del perfil bioquímico de moléculas pequeñas de sujetos individuales para el diagnóstico de enfermedad y evaluación de la salud

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5164778A (ja) * 1974-11-30 1976-06-04 Narimi Hiroyoshi Shindanki
US4233031A (en) * 1978-12-11 1980-11-11 Environmental Sciences Associates, Inc. Electrochemical testing system and method
US4511659A (en) * 1983-03-04 1985-04-16 Esa, Inc. Liquid chromatograph with electrochemical detector and method
US4404065A (en) * 1980-01-14 1983-09-13 Enviromental Sciences Associates, Inc. Electrochemical detection system and method of analysis
JPS58178481A (ja) * 1982-04-14 1983-10-19 Hitachi Ltd 病態診断方法
US4527240A (en) * 1982-12-29 1985-07-02 Kvitash Vadim I Balascopy method for detecting and rapidly evaluating multiple imbalances within multi-parametric systems
US4461830A (en) * 1983-01-20 1984-07-24 Buren Philpot V Jun Serum fibrinogen viscosity in clinical medicine

Also Published As

Publication number Publication date
AU5202186A (en) 1986-06-03
EP0201591B1 (de) 1993-02-10
DE3587091T2 (de) 1993-06-03
JPS62500805A (ja) 1987-04-02
DE3587091D1 (de) 1993-03-25
EP0201591A1 (de) 1986-11-20
WO1986003006A1 (en) 1986-05-22
EP0201591A4 (de) 1987-04-14

Similar Documents

Publication Publication Date Title
Ghez Input-output relations of the red nucleus in the cat
HUP0102661A2 (hu) BTK-inhibitorok és a BTK-inhibitorok azonosítására szolgáló eljárások, valamint alkalmazásuk
ATE362781T1 (de) System zur behandlung von bewegungs- fehlfunktionen
DE69604509T2 (de) Vorrichtung zur verabreichung von medikamenten und genen durch elektroporation
ATE368420T1 (de) Herzratenvaribilität als inkikator für körperliche belastbarkeit
EP1541193A4 (de) MEDIZINISCHES BEHANDLUNGSSYSTEM UNTER VERWENDUNG EINES BIOLOGISCHEN REGULIERUNGSFUNKTIONSVERûNDERERS, SCHRITTMACHERSYSTEM AUF BASIS DES MEDIZINISCHEN BEHANDLUNGSSYSTEMS, BLUTDRUCKREGULIERSYSTEM UND SYSTEM ZUR BEHANDLUNG VON HERZKRANKHEITEN
NO976063L (no) Fremgangsmåte for behandling av diabetes
BRPI0410296A (pt) sistema e método para a determinação da eficácia de tratamento de distúrbios neurológicos utilizando o eletroencefalograma
NO890224L (no) Fremgangsmaate og anordning for medisinsk behandling av den patologiske tilstand av ben.
CA2275504A1 (en) Pharmacogenetic methods for use in the treatment of nervous system diseases
DE69740073D1 (de) System zur modifikation von neuralem gewebe
DE69612020D1 (de) Vorrichtung und verfahren zur automatischen bestimmung von stimulationsparametern
DE50312005D1 (de) Medizinische Vorrichtung zur Modulation neuronaler Aktivität im Gehirn
DE69628912D1 (de) Herstellungb und verwendung eines spezifischen gaba-aalpha5 rezeptorligands zur behandlung der erkrankung von alzheimer
ATE350039T1 (de) Gefitinib (iressa) zur behandlung von krebs
ATE85707T1 (de) Entwicklungsverfahren fuer arzneimittel zur behandlung von stoerungen.
ATE181422T1 (de) Verfahren zur diagnose von praeklampsie
DE820303T1 (de) p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES
DE60218843D1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
ATE23107T1 (de) Vorrichtung fuer die behandlung von menieresymptomenkomplex und dergleichen.
GB2393547A (en) Method and system for improving vascular systems by biofeedback and networking
Fuhr et al. Electrocutaneous reflexes in upper limbs–reliability and normal values in adults
Cbiederman et al. Behavioral, physiological, and self-evaluative effects of anxiety on the self-control of pain
DE3650368T2 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
DE68909750T2 (de) Vorrichtung zur therapeutischen behandlung von lumbago sowie lumbago/ischias.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties